v3.26.3
Share Capital (Details Narrative) - Chemomab Therapeutics Ltd [Member] - USD ($)
 1 Months Ended 5 Months Ended 6 Months Ended 11 Months Ended 12 Months Ended 27 Months Ended
Jul. 25, 2024
Nov. 17, 2023
Nov. 16, 2022
Sep. 19, 2022
Apr. 25, 2022
Apr. 30, 2021
Mar. 22, 2021
Mar. 15, 2021
Jul. 31, 2025
Nov. 30, 2024
Oct. 31, 2023
Dec. 31, 2025
Jun. 30, 2026
Jun. 30, 2026
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2025
Description of american depositary shares ratio                             one ADS representing 80 Ordinary Shares (the “ADS Ratio Change”).        
Proceeds from sale of ADS's                     $ 2,863,664                
Proceeds from sale of treasury stock   $ 580,000                         $ 580,000    
Options to purchase ADS cancelled                         1,418,880   4,869,540 667,820 20,373,620    
2015 Plan [Member]                                      
Number of ADSs issued                             48,692        
Number of stock reserved for issuance                             28,443,060        
Number of stock adss resvered for issuance                             355,538        
Number of shares issued                             3,895,360        
Number of options issuable outstanding                             13,321,840        
Number of ADSs options issuable outstanding                             166,523        
Number of options vested and exercisable                             9,335,040        
Number of ADSs vested and exercisable                             116,688        
Weighted average exercise price                             $ 0.24        
Weighted average exercise price of ADSs                             $ 19.03        
Options to purchase ADS cancelled                             125,040        
Options to purchase ordinary shares cancelled                             1,563        
2015 Plan [Member] | Restricted Ordinary Shares [Member]                                      
Number of ADSs issued                             73,387 80,549      
Number of shares issued                             5,870,980 6,443,900      
Options to purchase ADS cancelled                             10,130        
Options to purchase ordinary shares cancelled                             810,400        
Number of shares converted into ordinary shares                             1,433,120        
Number of shares converted into ordinary shares, American Depositary Shares                             17,914        
2017 Plan [Member]                                      
Number of ADSs issued                             227,136        
Number of stock reserved for issuance                             23,061,380        
Number of stock adss resvered for issuance                             288,267        
Number of shares issued                             18,170,880        
Number of options vested and exercisable                             13,159,760        
Number of ADSs vested and exercisable                             164,497        
Weighted average exercise price                             $ 0.12        
Weighted average exercise price of ADSs                             $ 9.92        
Options to purchase ADS cancelled                             4,744,480        
Options to purchase ordinary shares cancelled                             59,306        
Lifesci Capital LLC [Member]                                      
Number of ADSs issued                 80     1,979,986 34,760 2,014,746          
Weighted average price of repurchase of ADSs                       $ 3.06 $ 2.01 $ 3.04          
Total consideration of repurchase of ADSs                 $ 7,260,000     $ 5,814,000 $ 68,000 $ 5,882,000          
Lifesci Capital LLC [Member] | Accounts Receivable [Member]                                      
Consideration of repurchase of ADS                       $ 44,000              
Private Placement [Member]                                      
Number of warrants purchase ADS's 1,037,217             654,818                      
Number of ADSs issued 987,075           65,482               65,482        
Share price per share $ 0.0004           $ 69.4                        
Proceeds from sale of ADS's $ 10,000,000.0           $ 4,500,000                        
Total consideration of repurchase of ADSs $ 9,071,000                                    
ATM Agreement [Member]                                      
Number of ADSs issued           174,952                     193,225 32,626  
Share price per share           $ 91                     $ 7.32 $ 8.44  
Proceeds from sale of ADS's         $ 18,125,000 $ 15,917,000                     $ 1,371,000 $ 275,000  
Aggregate offering price of at the market offering agreement           $ 75,000,000                          
Total consideration of repurchase of ADSs     $ 1,218,000                                
Repurchase Arrangement [Member]                                      
Number of shares repurchase of ADSs     145,506 145,506                              
Repurchase of ADSs       $ 2,500,000,000                              
Weighted average price of repurchase of ADSs     $ 8.34                                
Market Offering Agreement [Member]                                      
Proceeds from sale of ADS's                     $ 2,863,664                
Market Offering Agreement [Member] | Roth Capital Partners Llc [Member]                                      
Number of ADSs issued                                     847,912
Proceeds from sale of ADS's                   $ 8,626,564                  
Weighted average price of repurchase of ADSs                                     $ 4.70
Total consideration of repurchase of ADSs                             $ 1,343,000       $ 3,691,000